Al Nahdi Medical Company SCJSC
SAU:4164
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/GP
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Valuation Scenarios
If EV/GP returns to its 3-Year Average (4.8), the stock would be worth ﷼133.17 (3% upside from current price).
| Scenario | EV/GP Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 4.6 | ﷼129.2 |
0%
|
| 3-Year Average | 4.8 | ﷼133.17 |
+3%
|
| 5-Year Average | 5 | ﷼139.64 |
+8%
|
| Industry Average | 7.7 | ﷼214.19 |
+66%
|
| Country Average | 12.3 | ﷼342.51 |
+165%
|
Forward EV/GP
Today’s price vs future gross profit
Peer Comparison
| Market Cap | EV/GP | P/E | ||||
|---|---|---|---|---|---|---|
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR | 4.6 | 20.2 | |
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
62B ZAR | 5.4 | 19.2 | |
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
31.3B ZAR | 3.8 | 25.3 | |
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
10.4B USD | 0.7 | -1.6 | |
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
37.5B BRL | 3.5 | 29.5 | |
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
932.2B JPY | 2 | 21.8 | |
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
909.7B JPY | 2.1 | 16.2 | |
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
28.4B CNY | 2.5 | 16.4 | |
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY | 1.5 | 34.3 | |
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
566.4B JPY | 1.7 | 12.6 | |
| CN |
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
22B CNY | 2.2 | 17.1 |
Market Distribution
| Min | 2.4 |
| 30th Percentile | 8.4 |
| Median | 12.3 |
| 70th Percentile | 16.3 |
| Max | 315.2 |
Other Multiples
Al Nahdi Medical Company SCJSC
Glance View
Al Nahdi Medical Company SCJSC has entrenched itself as a prominent player within Saudi Arabia’s expansive healthcare and retail landscape. Founded in 1986, the company embarked on its journey as a single pharmacy in Jeddah, gradually evolving into the leading pharmacy retail chain in the Kingdom. This evolution is interwoven with the region’s healthcare development, echoing the burgeoning demands of a population increasingly focused on wellness and access to quality health products. Al Nahdi’s strategy hinges on an expansive network of over 1,100 outlets, strategically located not only to ensure accessibility but also to foster strong community ties by providing crucial health services and over-the-counter medications. The company's mission stretches beyond mere business growth; it strives to act as a supportive pillar in the community, exemplified by initiatives such as education programs and promoting public health awareness. Al Nahdi’s business model thrives on diversification and integration within the healthcare supply chain. Core revenue streams derive from retail sales of pharmaceuticals, cosmetics, and personal care products, enhanced by a digital presence that captures the rising trend of online shopping. Their omnichannel strategy, combining physical stores with a robust e-commerce platform, presents a seamless shopping experience tailored to the modern consumer. The company also capitalizes on strategic partnerships and alliances to enhance its product offerings, ensuring that it stays ahead in the competitive landscape. Through its efficient logistics network, Al Nahdi guarantees timely delivery and product availability, which are essential to maintaining customer loyalty and market leadership. This blend of expansive reach, customer-centric service, and strategic foresight not only fuels its profitability but solidifies its position as a healthcare cornerstone across the region.